Hai Yun
Chief Executive Officer bij Henan Furentang Pharmaceutical Co. Ltd.
Profiel
Hai Yun is currently the General Manager at Henan Furentang Pharmaceutical Co. Ltd.
Prior to this, from 2014 to 2023, he worked at FUREN Group Pharmaceutical Co., Ltd.
as a Member-Supervisory Board.
Actieve functies van Hai Yun
| Bedrijven | Functie | Begin |
|---|---|---|
Henan Furentang Pharmaceutical Co. Ltd.
 Henan Furentang Pharmaceutical Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of FUREN Group Pharmaceutical Co., Ltd., Henan Furentang Pharmaceutical Co. Ltd. manufactures and sells pharmaceutical products. The private company is based in Zhengzhou, China. The CEO of the Chinese company is Hai Yun. Henan Furentang Pharmaceutical Co. was acquired by FUREN Group Pharmaceutical Co., Ltd. from Henan Furen Medicines Group Co. Ltd. on April 25, 2005 for $20.82 million. | Chief Executive Officer | - |
Eerdere bekende functies van Hai Yun
| Bedrijven | Functie | Einde |
|---|---|---|
| FUREN GROUP PHARMACEUTICAL CO.,LTD. | Director/Board Member | 15-06-2023 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
FUREN Group Pharmaceutical Co., Ltd.
 FUREN Group Pharmaceutical Co., Ltd. BiotechnologyHealth Technology FUREN Group Pharmaceutical Co., Ltd. was engaged in the research and development, manufacture, and sale of pharmaceutical products. It offers chemical medicines, Chinese medicines, active pharmaceutical ingredients, and biopharmaceutical products. The company was founded by Wen Chen Zhu on August 13, 1993 and was headquartered in Zhengzhou, China. | Health Technology |
Henan Furentang Pharmaceutical Co. Ltd.
Henan Furentang Pharmaceutical Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of FUREN Group Pharmaceutical Co., Ltd., Henan Furentang Pharmaceutical Co. Ltd. manufactures and sells pharmaceutical products. The private company is based in Zhengzhou, China. The CEO of the Chinese company is Hai Yun. Henan Furentang Pharmaceutical Co. was acquired by FUREN Group Pharmaceutical Co., Ltd. from Henan Furen Medicines Group Co. Ltd. on April 25, 2005 for $20.82 million. | Health Technology |
